SynZeal product information given on this website is as per the existing understanding while publishing the details on website. The customer is responsible for assessing the accuracy of the information at the time of actual purchase.
SynZeal will update these details as per new development or finding in product specification without further noticed.
Nome Químico: 1-[[2-[(2-Aminophenyl)amino]-5-methyl-3-thienyl]carbonyl]-4-methyl-piperazine
Shipping Temperature: Ambient
HSN Code: 38229010
Country of Origin: India
Sorrisos: NC1=C(C=CC=C1)NC(SC(C)=C2)=C2C(N3CCN(C)CC3)=O
Olanzapine Amino Methanone Impurity is chemically 1-[[2-[(2-Aminophenyl)amino]-5-methyl-3-thienyl]carbonyl]-4-methyl-piperazine. Olanzapine Amino Methanone Impurity is supplied with detailed characterization data compliant with regulatory guideline. Olanzapine Amino Methanone Impurity can be used for the analytical method development, method validation (AMV), Quality Controlled (QC) application for Abbreviated New Drug Application (ANDA) or during commercial production of Olanzapine.
The product can be used as reference standards and further traceability against pharmacopeial standards (USP or EP) can be provided based on feasibility. SynZeal products are for analytical purpose only and not for human use.
RP-HPLC method development, validation and stability indicating study of olanzapine in tablet dosage form
By Bhatt, Rahul; Singh, Gurdeep; Tiwari, Apoorva; Jain, Neetesh K.
From International Journal of Pharmacy and Life Sciences (2020), 11(11), 7079-7084.
The analytical method development and validation for the simultaneous estimation of flouxetine & olanzapine by using RP-HPLC
By Patnaik, D. Kishore Kumar; Hotta, Santanu Kumar; Bangari, Chaitanya; Raju, M. B. Venkatapati
From Indo American Journal of Pharmaceutical Sciences (2020), 7(5), 680-698.
A validated stability indicating high performance liquid chromatographic method for olanzapine
By Rakibe, Udaykumar; Rane, Vipul; Yeole, Ravindra; Afnan, Ali; Wakte, Pravin
From Latin American Journal of Pharmacy (2017), 36(7), 1462-1468